See More
See Faster
See In Situ

Through ultrasensitive InSituPlex® assays and advanced, AI-driven spatial analysis, Ultivue empowers scientists developing precision cancer therapies to generate quantitative, high confidence insights in just a fraction of the time.

Turning tissues into actionable insights

Turning tissues into actionable insights

Design and deploy biomarker panels to profile the immune landscape in your tissues with unprecedented clarity through InSituPlex® technology.

Ultivue’s “end-to-end” solution encompasses:

  • Custom Assay Development
  • Pre-optimized Ready-to-Use Kits
  • Custom Assay Development Services
  • Specialized AI Tools for Image Analysis
  • Full Lifecycle Image Analysis Services

Ultivue is an ideal partner in your clinical biomarker development journey towards compelling results that move your science forward.

VUE
Biomarker
Panels

Ultivue’s proprietary InSituPlex® technology uses direct, linear amplification of antibody-linked tags to generate quantitatively consistent signals from multiple markers simultaneously.

Leveraging the InSituPlex® platform, VUE panels provide translational and clinical researchers with a portfolio of pre-optimized yet configurable, as well as custom biomarker assays.

VUE panel-derived data yield more precise insights than less quantitative methods quickly and cost-effectively – 70% faster while leveraging existing lab infrastructure.

Show more

Assay Development & Services

Ultivue Assay Services accelerate your research team’s path to precise visualization and robust analysis of proteins in the tissue microenvironment.

Areas of expertise include, Assay Design and Development, Proof of Concept (PoC) Design and Execution, Concordance Studies, Assay Verification/Validation and Clinical Trial Support.

An end-to-end solution empowers your team to attain quantitative insights in a fraction of the time, without in-house development costs.

Show more

Spatial
Image
Analysis

Ultivue’s Spatial Image Analysis pipeline uses AI and advanced analytics approaches to unlock precise, quantitative insights into the spatial biology of tumor microenvironments.

A cross-functional team of pathology, translational biology, and data science experts utilizes advanced Deep Learning and a proprietary image analysis pipeline to enhance your research, delivering comprehensive cell phenotyping and valuable cohort-level results.

An end-to-end solution, from biomarker assay to quantitative insight, empowers your team to make significant, data-driven research decisions in a fraction of the time and cost.

Show more

At Ultivue, we power insights through AI-driven, quantitative spatial proteomics.  We are inspired by the scientists we serve in translational and clinical research, mutually committed to realizing the full promise of precision medicine for cancer patients.

Rob Carson, President and CEO

Revealing the true state of cancer

Revealing the true state of cancer

What if you could answer the following?

What if you could answer the following?

Can I identify markers, phenotypes and spatial interactions which can best distinguish different patient groups?

Can I segment samples into treatment groups and learn how the tumor responds to treatment?

How do I compare tissues pre and post treatment to better understand drug action?

Can I reduce assay complexity to move into clinical practice?

How do I look for the more relevant assay design for my study?

Can I analyze drug treatment data to robustly determine key phenotypes that predict success?

Can I survey across multiple tumor types to find those with the most treatment potential?

To explore how quantitative spatial profiling could expand the depth and clarity of information and insights available for your research, please get in touch.

To explore how quantitative spatial profiling could expand the depth and clarity of information and insights available for your research, please get in touch.

On-Demand Webinar

On-Demand Webinar

Unraveling the Tumor Microenvironment Using Custom mIF Panels & Spatial Tissue Analysis

Watch Now